Core Wealth Partners LLC Makes New Investment in Lifevantage Corporation (NASDAQ:LFVN)

Key Points

• Core Wealth Partners LLC acquired a new stake in Lifevantage Corporation, purchasing 32,943 shares valued at approximately $480,000, representing 0.26% ownership at the end of the recent quarter.
• The stock price of Lifevantage has increased by 3.5%, with the stock opening at $13.76 and a current market cap of $173.24 million.
• Corporate insiders own 20.65% of Lifevantage's stock, and CFO Carl Aure sold 2,746 shares recently, decreasing their holdings by 2.02%.

Core Wealth Partners LLC acquired a new stake in shares of Lifevantage Corporation (NASDAQ:LFVN - Free Report) in the 1st quarter, according to its most recent 13F filing with the SEC. The fund acquired 32,943 shares of the company's stock, valued at approximately $480,000. Core Wealth Partners LLC owned 0.26% of Lifevantage at the end of the most recent quarter.

Several other large investors have also made changes to their positions in LFVN. Brown Advisory Inc. purchased a new position in shares of Lifevantage during the first quarter worth $150,000. Cannon Global Investment Management LLC purchased a new position in shares of Lifevantage during the 1st quarter valued at about $156,000. XTX Topco Ltd purchased a new position in shares of Lifevantage during the 1st quarter valued at about $186,000. Cambridge Investment Research Advisors Inc. lifted its holdings in shares of Lifevantage by 23.2% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 12,867 shares of the company's stock valued at $188,000 after buying an additional 2,421 shares during the period. Finally, Schonfeld Strategic Advisors LLC purchased a new stake in shares of Lifevantage in the fourth quarter worth about $282,000. 35.32% of the stock is owned by hedge funds and other institutional investors.

Lifevantage Stock Up 3.5%

Lifevantage stock opened at $13.76 on Tuesday. The business's 50-day moving average price is $12.88 and its 200 day moving average price is $14.54. The firm has a market cap of $173.24 million, a price-to-earnings ratio of 19.94 and a beta of 0.45. Lifevantage Corporation has a 52 week low of $7.09 and a 52 week high of $27.38.

Insider Buying and Selling

In other news, CFO Carl Aure sold 2,746 shares of Lifevantage stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $13.39, for a total transaction of $36,768.94. Following the completion of the transaction, the chief financial officer directly owned 133,303 shares of the company's stock, valued at $1,784,927.17. The trade was a 2.02% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 20.65% of the company's stock.

About Lifevantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.